Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Epithelial ovarian cancer (EOC) is the most lethal of the gynecological malignancies. Exploring the molecular mechanisms and major factors of invasion and metastasis could have great significance for the treatment and prognosis of EOC. Studies have demonstrated that microRNA 106b (miR-106b) may be a...
Main Authors: | Shuo Chen, Xi Chen, Yin-Ling Xiu, Kai-Xuan Sun, Yang Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4416747?pdf=render |
Similar Items
-
Role of the lncRNA ABHD11-AS1 in the tumorigenesis and progression of epithelial ovarian cancer through targeted regulation of RhoC
by: Dan-Dan Wu, et al.
Published: (2017-08-01) -
Research Progress of Relationship Between RhoC and Tumor Angiogenesis
by: LIU Kai, et al.
Published: (2018-02-01) -
The Involvement of RhoA and Wnt-5a in the Tumorigenesis and Progression of Ovarian Epithelial Carcinoma
by: Shuo Chen, et al.
Published: (2013-12-01) -
A RhoC biosensor reveals differences in the activation kinetics of RhoA and RhoC in migrating cells.
by: Jon S Zawistowski, et al.
Published: (2013-01-01) -
The transcription factor FOXA1 induces epithelial ovarian cancer tumorigenesis and progression
by: Li-Li Wang, et al.
Published: (2017-05-01)